Kidney Week

Special Session

Plenary: In Memoriam, State-of-the-Art Panel "Xenotransplantation Advances"

November 09, 2025 | 08:00 AM - 08:45 AM

Location: Hall A, Convention Center

Session Description

Xenotransplantation has seen significant advances, driven by the organ shortage crisis and a sustainable alternative to human organ donation. March 2024 marked the first human to receive a genetically modified pig kidney transplant, followed by the first combined heart pump and pig kidney transplant in April 2024. Earlier this year, the US Food and Drug Administration (FDA) announced clearance of clinical trials for genetically modified pig kidney transplants in humans. ASN has assembled an expert panel to discuss xenotransplant topics, including surgery and protocols, ethics and selection, translational science, and payment considerations.

Note: Continuing education credits are not being offered for this session.

Support for this session is provided by Vera Therapeutics.

Learning Objective(s)

• Discuss xenotransplantation surgery and protocols
• Discuss xenotransplantation ethics and selection
• Discuss xenotransplantation payment considerations

Learning Pathway(s)

• Kidney Transplantation

Presentations

• In Memoriam
  08:00 AM - 08:05 AM
  

In Memoriam

November 09, 2025 | 08:00 AM - 08:05 AM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• State-of-the-Art Panel "Xenotransplantation Advances"
  08:05 AM - 08:45 AM
  
  • David KC Cooper, MD, MA, MS, PhD
  • Paul E. Klotman, MD
  • Rachel Meyer
  • Robert Avery Montgomery, MD, PhD
  • Leonardo V. Riella, MD, PhD, FASN

State-of-the-Art Panel "Xenotransplantation Advances"

November 09, 2025 | 08:05 AM - 08:45 AM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.